Beijing Science Sun Pharmaceutical Co Ltd
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, among others. It is also involved in the research, development, production, and sale of raw materials; the extraction of traditional Chin… Read more
Beijing Science Sun Pharmaceutical Co Ltd (300485) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.008x
Based on the latest financial reports, Beijing Science Sun Pharmaceutical Co Ltd (300485) has a cash flow conversion efficiency ratio of 0.008x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.68 Million) by net assets (CN¥3.43 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beijing Science Sun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Beijing Science Sun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Beijing Science Sun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Science Sun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dongjiang Environmental Company Limited
PINK:SZDEF
|
0.038x |
|
Frey SA
PA:FREY
|
0.059x |
|
Infibeam Avenues Limited
NSE:INFIBEAM
|
0.023x |
|
Zhejiang Xiantong Rubber&Plastic Co Ltd
SHG:603239
|
0.061x |
|
NOTE AB SK-50
F:NQA
|
N/A |
|
Versamet Royalties Corporation
TO:VMET
|
0.033x |
|
Dalian Haosen Equipment Manufacturing Co. Ltd. A
SHG:688529
|
-0.018x |
|
Changzhou Almaden Co Ltd
SHE:002623
|
-0.016x |
Annual Cash Flow Conversion Efficiency for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.39 Billion | CN¥135.97 Million | 0.040x | +556.62% |
| 2023-12-31 | CN¥3.47 Billion | CN¥21.21 Million | 0.006x | -81.10% |
| 2022-12-31 | CN¥3.41 Billion | CN¥110.43 Million | 0.032x | -42.03% |
| 2021-12-31 | CN¥3.28 Billion | CN¥183.30 Million | 0.056x | -39.67% |
| 2020-12-31 | CN¥2.85 Billion | CN¥263.73 Million | 0.093x | +45.43% |
| 2019-12-31 | CN¥2.71 Billion | CN¥172.52 Million | 0.064x | +10.99% |
| 2018-12-31 | CN¥2.56 Billion | CN¥146.52 Million | 0.057x | +22.89% |
| 2017-12-31 | CN¥2.32 Billion | CN¥108.21 Million | 0.047x | -54.03% |
| 2016-12-31 | CN¥2.10 Billion | CN¥212.89 Million | 0.101x | +12.82% |
| 2015-12-31 | CN¥1.88 Billion | CN¥169.36 Million | 0.090x | -72.85% |
| 2014-12-31 | CN¥646.64 Million | CN¥214.23 Million | 0.331x | -16.90% |
| 2013-12-31 | CN¥493.71 Million | CN¥196.82 Million | 0.399x | -5.55% |
| 2012-12-31 | CN¥359.96 Million | CN¥151.93 Million | 0.422x | +35.50% |
| 2011-12-31 | CN¥247.37 Million | CN¥77.06 Million | 0.312x | -- |